BWCS

Beirne Wealth Consulting Services’s Lineage Cell Therapeutics LCTX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$40.8K	Hold	45,000	–	–	0.01%	103
2025 Q1	$20.3K	Hold	45,000	–	–	0.01%	102
2024 Q4	$22.6K	Hold	45,000	–	–	0.01%	98
2024 Q3	$40.7K	Hold	45,000	–	–	0.01%	101
2024 Q2	$44.9K	Hold	45,000	–	–	0.02%	97
2024 Q1	$66.6K	Hold	45,000	–	–	0.03%	98
2023 Q4	$49.1K	Hold	45,000	–	–	0.02%	151
2023 Q3	$63.5K	Hold	45,000	–	–	0.05%	91
2023 Q2	$63.5K	Hold	45,000	–	–	0.05%	91
2023 Q1	$67.5K	Hold	45,000	–	–	0.05%	95
2022 Q4	$52.7K	Hold	45,000	–	–	0.03%	88
2022 Q3	$51K	Hold	45,000	–	–	0.02%	97
2022 Q2	$71K	Hold	45,000	–	–	0.05%	89
2022 Q1	$70K	Hold	45,000	–	–	0.04%	93
2021 Q4	$110K	Hold	45,000	–	–	0.06%	99
2021 Q3	$113K	Hold	45,000	–	–	0.06%	107
2021 Q2	$128K	Hold	45,000	–	–	0.07%	109
2021 Q1	$106K	Hold	45,000	–	–	0.06%	104
2020 Q4	$79K	Hold	45,000	–	–	0.04%	160
2020 Q3	$42K	Sell	45,000 -25,000	-36%	-$23.3K	0.02%	136
2020 Q2	$61K	Buy	70,000 +25,000	+56%	+$21.8K	0.05%	75
2020 Q1	$37K	Hold	45,000	–	–	0.04%	70
2019 Q4	$40K	Hold	45,000	–	–	0.04%	93
2019 Q3	$44K	Hold	45,000	–	–	0.04%	135
2019 Q2	$50K	Buy	45,000 +20,000	+80%	+$22.2K	0.04%	132
2019 Q1	$33K	Buy	25,000 +5,000	+25%	+$6.6K	0.03%	186
2018 Q4	$18K	Buy	+20,000	New	+$18K	0.02%	177